Code Snippets
curl "https://financialdata.net/api/v1/executive-compensation?identifier=BAX&key=API_KEY"import requests
url = 'https://financialdata.net/api/v1/executive-compensation?identifier=BAX&key=API_KEY'
response = requests.get(url)
print(response.json())
const url = 'https://financialdata.net/api/v1/executive-compensation?identifier=BAX&key=API_KEY';
const response = await fetch(url);
const data = await response.json();
console.log(data);
Sample Response
[
{
"trading_symbol": "BAX",
"central_index_key": "0000010456",
"registrant_name": "BAXTER INTERNATIONAL INC",
"executive_name": "Andrew Hider",
"executive_position": "CEO, President",
"fiscal_year": "2025",
"salary": 499315.0,
"bonus": 1000000.0,
"stock_awards": 23133518.0,
"incentive_plan_compensation": 820125.0,
"other_compensation": 1167171.0,
"total_compensation": 29805182.0
},
...
]Query Parameters
| Name | Type | Description |
|---|---|---|
| identifier | string | The trading symbol for a security, or the central index key (CIK). The latter is assigned to the entity by the United States Securities and Exchange Commission. (e.g., MSFT, 0000789019) |
| offset | integer | (Optional) The initial position of the record subset, which indicates how many records to skip. Defaults to 0. (e.g., 100) |
| format | string | (Optional) The format of the returned data, either JSON or CSV. Defaults to JSON. (e.g., json, csv) |
Endpoint Overview
Executive compensation includes both financial and non-financial benefits provided by their employer. It is usually a combination of a base salary, variable performance-based bonuses, and other benefits. The API endpoint provides historical executive compensation data for several thousand US and international companies. There is a limit of 100 records per API call.
Company Profile
BAXTER INTERNATIONAL INC
NYSE: BAX- Market Cap:$16.00B
- ISIN:US0718131099
- Fiscal Year End:12/31
- CEO:Andrew Hider
- Employees:38000
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat chronic and acute medical conditions. The company had 2023 global net sales of $14.8 billion (+2% vs 2022), across three business: "Medical Product and Therapies", "Healthcare Systems and Technologies" and Pharmaceuticals.